Pacira BioSciences (PCRX) Assets (2010 - 2026)
Pacira BioSciences' Assets came in at $1.24 billion for Q2 2026, down 19.1% from $1.54 billion a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Pacira BioSciences' Assets was $1.26 billion, down 18.6% from FY2024.
- Assets has declined in each of the last four years, with a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Going back by year, Assets was $1.55 billion in FY2024 (-1.3%), $1.57 billion in FY2023 (-6.4%), $1.68 billion in FY2022 (-19.0%) and $2.08 billion in FY2021 (+62.8%).
- The five-year range for quarterly Assets is $1.21 billion (Q1 2026) to $2.08 billion (Q4 2021).
- Year-over-year, Assets has declined for five consecutive quarters, with an average decline of 10.6% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 62.8%), and the weakest in Q1 2026 (a decline of 23.8%).
- Business Quant data shows PCRX's Assets at $1.21 billion (Q1 2026), $1.26 billion (Q4 2025) and $1.3 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 1.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Bn |
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.30 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.53 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.52 Bn |
| Dec 31, 2022 | 1.68 Bn |
| Sep 30, 2022 | 1.73 Bn |
| Jun 30, 2022 | 1.73 Bn |
| Mar 31, 2022 | 1.89 Bn |
| Dec 31, 2021 | 2.08 Bn |
| Sep 30, 2021 | 1.36 Bn |
API Access
Pacira BioSciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();